Search results

New facility will greatly enhance Australia’s capability in stress engineering for industry

Today Dr Jenine McCutcheon from the University of Queensland’s School of Earth and Environmental Sciences has been recognised for her outstanding research with the Australian Synchrotron's Stephen Wilkins Medal.

ANSTO’s National Deuteration Facility has been providing high-quality deuterated lipids used in the construction of cell membrane models to support research that improves our understanding of how the virus interacts with elements of the cell membrane, a relatively new area of investigation.

ANSTO will be participating in a new Industrial Transformation Training Centre established and funded by the Australia Research Council to advance the use of bioactive ingredients in Australia.

New high energy ion microprobe beamline supports space research on the effects of radiation on astronauts.

Insights into atomic structure

ANSTO is pleased to welcome The Hon Dr Annabelle Bennett AO SC as the new ANSTO Board Chairperson, following the announcement from the Minister for Industry, Science and Technology. 

Timetable and Teams links

Atmospheric scientists have developed a new technique to measures the naturally-occurring radioactive gas radon for use in accurately categorising the degree of atmospheric mixing.

The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been appointed Chief Executive Officer of ANSTO following a global search for the position.

Dr Mitra Safavi Naeini continues her commentary of the radiation studies being undertaken in the Artemis II mission.

Project Bright, the construction of eight new beamlines at ANSTO’s Australian Synchrotron has reached a milestone by achieving ‘First Light’ for the new micro-computed tomography (MCT) beamline in late NovembeR.

ANSTO’s National Deuteration Facility has provided deuterated cholesterol for international research to gain a better understanding of how the Spike protein of the COVID virus, SARS-Co-V-2, infects human cells through a membrane fusion mechanism.